European Journal of Haematology
Издатель: Wiley · ISSN 09024441 · 56 статей
-
Bleeding Symptoms, Laboratory, and Molecular Genetic Results in Children With Platelet Disorders
ABSTRACT Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study...
-
Efficacy, Safety, and Durability of Sutimlimab in Cold Agglutinin Disease: A Systematic Review and Meta‐Analysis
ABSTRACT Introduction Sutimlimab, a C1s inhibitor, is the only agent approved for hemolysis in cold agglutinin disease (CAD). Its evidence base has expanded through extensions, access programs, and registries that may re‐report...
-
Chronic Lymphocytic Leukaemia as a Disease of Time: A Four‐Clock Framework for Therapeutic Stewardship
ABSTRACT Chronic lymphocytic leukaemia (CLL) is defined not only by disease biology but also by time. Its natural history reflects the pace of clonal evolution, the changing reserve of host immunity, the ordered use of therapeutic...
-
Comparative Prognostic Value of Mayo 2012 and European‐Modified Mayo 2004 Staging Systems in Systemic AL Amyloidosis With Discordant Risk Classification
ABSTRACT Objectives The Mayo 2012 and European‐modified Mayo 2004 (European‐modified) staging systems are widely used in systemic light‐chain (AL) amyloidosis, but their comparative prognostic performance in patients with discordant...
-
Optimizing Frontline Targeted Therapies in Chronic Lymphocytic Leukemia: An Italian Inter‐Regional Delphi Consensus on Patient Risk Stratification, Cardiovascular Safety, and Endpoint Interpretation
ABSTRACT Background While landmark trial data have established targeted agents as the frontline standard of care in chronic lymphocytic leukemia (CLL), real‐world clinical gaps remain regarding high‐risk disease biology, patient...
-
Patient‐Reported Symptom Burden and Objective Responses After Belumosudil in Heavily Pretreated Chronic GvHD
ABSTRACT Background Belumosudil has demonstrated clinical activity in chronic graft‐versus‐host disease (cGvHD), but its impact on patient‐reported symptom burden in routine practice remains incompletely characterized. Objective To...
-
Beyond Dendritic Cells: A Cellular Pharmacology Agenda for mRNA Cancer Vaccines in Hematologic Malignancies
ABSTRACT Background mRNA‐based vaccines are emerging as a promising platform for cancer immunotherapy, including in hematologic malignancies. Current vaccine development has largely focused on antigen selection, mRNA engineering, lipid...
-
Underweight BMI Independently Predicts Inferior Survival in DLBCL Treated With R‐CHOP: A Lymphoma Registry Study
European Journal of Haematology, Volume 117, Issue 6, Page 1573-1582, December 2026.
-
Reduced Circulating Regulatory T Cells in Autoimmune and Chronic Idiopathic Neutropenia of Childhood: An Observational Study of Clinical and Laboratory Associations
European Journal of Haematology, Volume 117, Issue 6, Page 1647-1658, December 2026.
-
Von Willebrand Factor and ADAMTS13 in Relation to Atherosclerosis in the General Population: The Rotterdam Study
European Journal of Haematology, Volume 117, Issue 6, Page 1637-1646, December 2026.
-
Diagnostic Accuracy of Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Differentiating Tumor and Bland Thrombus in Patients With Cancer: A Systematic Review and Meta‐Analysis
European Journal of Haematology, Volume 117, Issue 6, Page 1622-1629, December 2026.
-
Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non‐Hodgkin Lymphoma on Reproduction Patterns
European Journal of Haematology, Volume 117, Issue 6, Page 1601-1611, December 2026.
-
Cardiac Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With First‐Line Ibrutinib–Venetoclax
European Journal of Haematology, Volume 117, Issue 6, Page 1612-1621, December 2026.
-
A Phase IIa, Double Blind, Randomized, Placebo Controlled, Parallel, Multicentre, Proof‐of‐Concept Study to Evaluate the Efficacy and Safety of Desidustat Oral Tablet for Treatment of Sickle Cell Disease
European Journal of Haematology, Volume 117, Issue 6, Page 1593-1600, December 2026.
-
Clonal Dynamics of GPI‐Deficient Cells in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): A Retrospective Follow‐Up Analysis
European Journal of Haematology, Volume 117, Issue 6, Page 1583-1592, December 2026.
-
Long‐Term Clinical Outcomes, Adherence, Persistence, and Adverse Event Management in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib
European Journal of Haematology, Volume 117, Issue 6, Page 1562-1572, December 2026.
-
Thrombotic Microangiopathy‐Like Phenotype in Patients With Infection‐Associated Disseminated Intravascular Coagulation Treated With Thrombomodulin Alfa
European Journal of Haematology, Volume 117, Issue 6, Page 1552-1561, December 2026.
-
Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases
European Journal of Haematology, Volume 117, Issue 6, Page 1531-1540, December 2026.
-
Economic Burden of Chronic Lymphocytic Leukaemia in Australia
European Journal of Haematology, Volume 117, Issue 6, Page 1541-1551, December 2026.
-
SKY92 Identifies High‐Risk Newly Diagnosed Multiple Myeloma With Inferior Progression‐Free Survival and Implicates NUF2 as a Candidate Driver
European Journal of Haematology, Volume 117, Issue 6, Page 1518-1530, December 2026.
-
InflaMix Predicts Severe CRS, ICU Admission, and Progression‐Free Survival After CAR‐T Therapy in LBCL
European Journal of Haematology, Volume 117, Issue 6, Page 1630-1636, December 2026.
-
Bone Marrow Fibrosis as a Predictor of Extramedullary Disease in Multiple Myeloma
European Journal of Haematology, Volume 117, Issue 6, Page 1659-1664, December 2026.
-
Zero Confirmed Transmissions Require a Denominator
European Journal of Haematology, Volume 117, Issue 6, Page 1676-1677, December 2026.
-
Extracellular Vesicle‐Based Approaches in Acute Myeloid Leukemia: Therapeutic Potential and Translational Challenges
European Journal of Haematology, Volume 117, Issue 6, Page 1500-1517, December 2026.
-
Hyperferritinemia: Pathophysiology, Etiologies, and Diagnostic Approach
European Journal of Haematology, Volume 117, Issue 6, Page 1442-1460, December 2026.
-
From Immune Dysfunction to Clinical Risk: Infections in Myelofibrosis
European Journal of Haematology, Volume 117, Issue 6, Page 1475-1484, December 2026.
-
Bispecific Antibodies and T‐Cell Engagers in Multiple Myeloma
European Journal of Haematology, Volume 117, Issue 6, Page 1461-1474, December 2026.
-
Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis
European Journal of Haematology, Volume 117, Issue 6, Page 1485-1499, December 2026.
-
Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants
European Journal of Haematology, Volume 117, Issue 6, Page 1421-1441, December 2026.
-
Issue Information
European Journal of Haematology, Volume 117, Issue 6, Page 1409-1412, December 2026.